TIL

Instil Bio, Inc. - Common Stock (TIL)

About Instil Bio, Inc. - Common Stock (TIL)

Instil Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.

Details

Daily high

$7.17

Daily low

$7.00

Price at open

$7.02

52 Week High

$21.98

52 Week Low

$5.67

Market cap

47.9M

Dividend yield

Volume

11,797

Avg. volume

14,881

P/E ratio

-1.58

Instil Bio, Inc. - Common Stock News